- Home
- NTES vs TAK Comparison
NTES vs TAK Comparison
Compare NTES & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTES | TAK |
|---|---|---|
| Founded | 1997 | 1781 |
| Country | China | Japan |
| Employees | 26028 | 47455 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2B | 56.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NTES | TAK |
|---|---|---|
| Price | $113.20 | $18.46 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $160.00 | N/A |
| AVG Volume (30 Days) | 577.7K | ★ 2.9M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | 2.60% | ★ 2.83% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.57 | $0.38 |
| Revenue Next Year | $8.57 | $1.02 |
| P/E Ratio | $79.88 | ★ $41.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $95.02 | $12.99 |
| 52 Week High | $159.55 | $18.90 |
Technical Indicators
Market Signals| Indicator | NTES | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 44.78 | 54.40 |
| Support Level | $111.48 | $17.65 |
| Resistance Level | $119.94 | $18.74 |
| Average True Range (ATR) | 1.86 | 0.28 |
| MACD | 0.47 | 0.02 |
| Stochastic Oscillator | 62.08 | 62.33 |
Price Performance
Historical ComparisonAbout NTES NetEase Inc.
Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.